A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone)

Scientific World Journal

Volumn 2015, Issue , 2015, Pages

  Ahmad, Bilal ^a   Rehman, Muneeb U ^a   Amin, Insha ^a   Arif, Ahmad ^a   Rasool, Saiema ^b   Bhat, Showkat Ahmad ^a   Afzal, Insha ^a   Hussain, Ishraq ^a   Bilal, Sheikh ^a   Mir, Manzoor Ur Rahman ^a  

^a SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANXIOLYTIC AGENT; APPETITE STIMULANT; EUGENOL; NATURAL PRODUCT; PARADOL; REACTIVE NITROGEN SPECIES; SHOGAOL; UNCLASSIFIED DRUG; VANILLIN; ZINGERONE; ANTIDIARRHEAL AGENT; GUAIACOL; PLANT EXTRACT; RADIOPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANTIDIABETIC ACTIVITY; ANTIDIARRHEAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CLOVE; GINGER; HUMAN; IMMUNOSTIMULATION; NONHUMAN; RADIATION PROTECTION; REVIEW; TRADITIONAL MEDICINE; VANILLA; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; LIPOLYSIS;

ANIMALIA; SYZYGIUM AROMATICUM; ZINGIBER OFFICINALE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIDIARRHEALS; ANTIEMETICS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; GINGER; GUAIACOL; HUMANS; LIPOLYSIS; PLANT EXTRACTS; RADIATION-PROTECTIVE AGENTS;

EID: 84935833571     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2015/816364     Document Type: Review

References (44)

1. E. J. Park and J. M. Pezzuto, "Botanicals in cancer chemoprevention, " Cancer and Metastasis Reviews, vol. 21, no. 3-4, pp. 231-255, 2002.
2. Y.-X. Zhang, J.-S. Li, L.-H. Chen, W.-W. Peng, and B.-C. Cai, "Simultaneous determination of five gingerols in raw and processed ginger by HPLC, " Chinese Pharmaceutical Journal, vol. 47, no. 6, pp. 471-474, 2012.
3. W. J. Cotton, "Production of zingerone, " Google Patents, 1945.
4. M. Takizawa, M. Sato, H. Kusuoku, and M. Sakasai, "Lipolysis stimulator, " Google Patents, 2012.
5. I. Rajan, N. Narayanan, R. Rabindran, P. R. Jayasree, and P. R. Manish Kumar, "Zingerone protects against stannous chloride-induced and hydrogen peroxide-induced oxidative DNA damage in vitro, " Biological Trace Element Research, vol. 155, no. 3, pp. 455-459, 2013.
6. M. K. Kim, S. W. Chung, J. M. Kim, et al., "Modulation of age-related NF-κB activation by dietary zingerone via MAPK pathway, " Experimental Gerontology, vol. 45, no. 6, pp. 419-426, 2010.
7. R. Vinothkumar, M. Sudha, and N. Nalini, "Chemopreventive effect of zingerone against colon carcinogenesis induced by 1, 2-dimethylhydrazine in rats, " European Journal of Cancer Prevention, vol. 23, no. 5, pp. 361-371, 2014.
8. L. Kumar, S. Chhibber, and K. Harjai, "Zingerone inhibit biofilm formation and improve antibiofilm efficacy of ciprofloxacin against Pseudomonas aeruginosa PAO1, " Fitoterapia, vol. 90, pp. 73-78, 2013.
9. D. V. Rajakumar and M. N. A. Rao, "Dehydrozingerone and its analogues as inhibitors of nonenzymatic lipid peroxidation, " Pharmazie, vol. 49, no. 7, pp. 516-519, 1994.
10. D. Banji, O. J. F. Banji, B. Pavani, C. Kranthi Kumar, and A. R. Annamalai, "Zingerone regulates intestinal transit, attenuates behavioral and oxidative perturbations in irritable bowel disorder in rats, " Phytomedicine, vol. 21, no. 4, pp. 423-429, 2014.
11. K. Vaibhav, P. Shrivastava, R. Tabassum, et al., "Delayed administration of zingerone mitigates the behavioral and histological alteration via repression of oxidative stress and intrinsic programmed cell death in focal transient ischemic rats, " Pharmacology Biochemistry and Behavior, vol. 113, pp. 53-62, 2013.
12. S.-G. Shin, Y. K. Ji, Y. C. Hae, and J.-C. Jeong, "Zingerone as an antioxidant against peroxynitrite, " Journal of Agricultural and Food Chemistry, vol. 53, no. 19, pp. 7617-7622, 2005.
13. K. L. Hemalatha, P. Stanley, and M. Prince, "Antihyperlipidaemic, antihypertrophic and reducing effects of Zingerone on experimentally iso-proterenol inducedmyocardial infracted rats, " Journal of Biochemical and Molecular Toxicology, vol. 29, no. 4, pp. 182-188, 2015.
14. T. Emmanuel, B. Aristide, T. Leopold, N. M. Benoit, and M. T. Joseph, "Phytochemical screening, chemical composition and antimicrobial activity of Zingiber officinale essential oil of Adamaoua region (Cameroon), " Journal of Chemical and Pharmaceutical Research, vol. 5, no. 7, pp. 296-301, 2013.
15. E. McNeill and N. Hogg, "S100A9 has a protective role in inflammation-induced skin carcinogenesis, " International Journal of Cancer, vol. 135, no. 4, pp. 798-808, 2014.
16. H. Kabuto and T. T. Yamanushi, "Effects of zingerone 4-(4-hydroxy-3-methoxyphenyl)-2-butanone and eugenol 2-methoxy-4-(2-propenyl)phenol on the pathological progress in the 6-hydroxydopamine-induced parkinsons disease mouse model, " Neurochemical Research, vol. 36, no. 12, pp. 2244-2249, 2011.
17. H. Kabuto, M. Nishizawa, M. Tada, C. Higashio, T. Shishibori, and M. Kohno, "Zingerone 4-(4-hydroxy-3-methoxyphenyl)-2-butanone prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum, " Neurochemical Research, vol. 30, no. 3, pp. 325-332, 2005.
18. S. W. Chung, M. K. Kim, J. H. Chung, et al., "Peroxisome proliferator-activated receptor activation by a short-term feeding of zingerone in aged rats, " Journal ofMedicinal Food, vol. 12, no. 2, pp. 345-350, 2009.
19. C.-Y. Hsiang, H.-Y. Lo, H.-C. Huang, C.-C. Li, S.-L. Wu, and T.-Y. Ho, "Ginger extract and zingerone ameliorated trinitrobenzene sulphonic acid-induced colitis in mice via modulation of nuclear factor-βB activity and interleukin-1β signalling pathway, " Food Chemistry, vol. 136, no. 1, pp. 170-177, 2013.
20. L. Kumar, S. Chhibber, and K. Harjai, "Hepatoprotective effect of zingerone (4-(4-hydroxy-3-methoxyphenyl) butan-2-one) in lipopolysaccharide induced liver injury mouse model through down regulation of inflammatory mediators, " International Journal of Pharmacognosy and Phytochemical Research, vol. 6, no. 2, pp. 308-314, 2014.
21. J.-C. Chen, L.-J. Huang, S.-L. Wu, S.-C. Kuo, T.-Y. Ho, and C.-Y. Hsiang, "Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice, " Journal of Agricultural and Food Chemistry, vol. 55, no. 21, pp. 8390-8397, 2007.
22. M. Iwami, T. Shiina, H. Hirayama, T. Shima, T. Takewaki, and Y. Shimizu, "Inhibitory effects of zingerone, a pungent component of Zingiber officinale Roscoe, on colonicmotility in rats, " Journal of Natural Medicines, vol. 65, no. 1, pp. 89-94, 2011.
23. L. Liu, J. M. Welch, R. P. Erickson, P. H. Reinhart, and S. A. Simon, "Different responses to repeated applications of zingerone in behavioral studies, recordings from intact and cultured TG neurons, and from VR1 receptors, " Physiology & Behavior, vol. 69, no. 1, pp. 177-186, 2000.
24. J. Bratton, P. A. S. Johnstone, and K. P. McMullen, "Outpatient management of vascular access devices in children receiving radiotherapy: complications and morbidity, " Pediatric Blood & Cancer, vol. 61, no. 3, pp. 499-501, 2014.
25. B. N. Rao, B. S. S. Rao, B. K. Aithal, and M. R. S. Kumar, "Radiomodifying and anticlastogenic effect of Zingerone on Swiss albino mice exposed to whole body gamma radiation, " Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 677, no. 1-2, pp. 33-41, 2009.
26. N. Motohashi, Y. Ashihara, C. Yamagami, and Y. Saito, "Antimutagenic effects of dehydrozingerone and its analogs on UVinduced mutagenesis in Escherichia coli, " Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 377, no. 1, pp. 17-25, 1997.
27. L. J. Buccellato, M. Tso, O. I. Akinci, N. S. Chandel, and G. R. S. Budinger, "Reactive oxygen species are required for hyperoxiainduced Bax activation and cell death in alveolar epithelial cells, " The Journal of Biological Chemistry, vol. 279, no. 8, pp. 6753-6760, 2004.
28. S. Cory and J. M. Adams, "The BCL2 family: regulators of the cellular life-or-death switch, " Nature Reviews Cancer, vol. 2, no. 9, pp. 647-656, 2002.
29. M. B. Sporn, "Approaches to prevention of epithelial cancer during the preneoplastic period, " Cancer Research, vol. 36, no. 7, pp. 2699-2702, 1976.
30. B. B. Aggarwal and S. Shishodia, "Molecular targets of dietary agents for prevention and therapy of cancer, " Biochemical Pharmacology, vol. 71, no. 10, pp. 1397-1421, 2006.
31. Y.-J. Surh, "Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances, " Mutation Research/Fundamental and MolecularMechanisms ofMutagenesis, vol. 428, no. 1-2, pp. 305-327, 1999.
32. Y.-J. Surh, "Cancer chemoprevention with dietary phytochemicals, " Nature Reviews Cancer, vol. 3, no. 10, pp. 768-780, 2003.
33. A. K. Pillai, K. K. Sharma, Y. K. Gupta, and S. Bakhshi, "Antiemetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy, " Pediatric Blood&Cancer, vol. 56, no. 2, pp. 234-238, 2011.
34. J. L. Ryan, C. E. Heckler, J. A. Roscoe, et al., "Ginger reduces acute chemotherapy induced nausea: a URCCCCOP study of patients, " Support Care Cancer, vol. 20, pp. 1479-1489, 2012.
35. Z. Jin, G. Lee, S. Kim, C.-S. Park, Y. S. Park, and Y.-H. Jin, "Ginger and its pungent constituents non-competitively inhibit serotonin currents on visceral afferent neurons, " The Korean Journal of Physiology & Pharmacology, vol. 18, no. 2, pp. 149-153, 2014.
36. S. S. Sharma, V. Kochupillai, S. K. Gupta, S. D. Seth, and Y. K. Gupta, "Antiemetic efficacy of ginger (Zingiber officinale) against cisplatin-induced emesis in dogs, " Journal of Ethnopharmacology, vol. 57, no. 2, pp. 93-96, 1997.
37. WorldHealthOrganization, "Obesity preventing and managing the global epidemic, report of a WHO consultation, " WHO Technical Report Series 894, WHO, 2000.
38. R. M. Pinder, R. N. Brogden, P. R. Sawyer, T. M. Speight, and G. S. Avery, "Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity, " Drugs, vol. 10, no. 4, pp. 241-323, 1975.
39. F. Brenot, P. Herve, P. Petitpretz, F. Parent, P. Duroux, and G. Simonneau, "Primary pulmonary hypertension and fenfluramine use, " British Heart Journal, vol. 70, no. 6, pp. 537-541, 1993.
40. J. P. Park, J. H. Kim, M. K. Park, and J. W. Yun, "Potential agents for cancer and obesity treatment with herbal medicines from the green garden, " Biotechnology and Bioprocess Engineering, vol. 16, no. 6, pp. 1065-1076, 2011.
41. B. A. Swinburn, I. Caterson, J. C. Seidell, and W. P. T. James, "Diet, nutrition and the prevention of excess weight gain and obesity, " Public Health Nutrition, vol. 7, no. 1A, pp. 123-146, 2004.
42. K. A. Amin and M. A. Nagy, "Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats, " Diabetology & Metabolic Syndrome, vol. 1, article 17, 14 pages, 2009.
43. L.-K. Han, C. Morimoto, Y.-N. Zhenget al., "Effects of zingerone on fat storage in ovariectomized rats, " Yakugaku Zasshi, vol. 128, no. 8, pp. 1195-1201, 2008.
44. K. Thunchomnang, K. Lawa, A. Mangkhalathon, P. Saenubol, S. Rattanakiat, and P. Pulbutr, "Lipolytic effects of zingerone in isolated rat adipocytes, " in Proceedings of the 4th Annual Northeast Pharmacy Research Conference, 2012.